Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Reorganizes Business Into Three Units

NEW YORK, March 1, (GenomeWeb News) - Clinical Data today said it has reorganized its business into three units: PGxHealth, Cogenics, and Vital Diagnostics.

 

The PGX Health division includes assets from newly acquired Genaissance. The unit is developing CNS, cardiovascular, and oncology tests, the company said.

 

The Cogenics unit, which represents the combined operations and marketing infrastructure of Genaissance, Lark, and Icoria to provide comprehensive pharmacogenomics and molecular services, is developing GLP-validated and research assays.

 

Vital Diagnostics, derived from the operations of Clinical Data, Vital, and Electa Labs, is geared toward IVD services for customers in 100 countries.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more